Changes in liver morphology and biochemistry have been assessed 16 hr after a sc injection of sodium arsenite [As(III), 75 &mu;mol/ kg] to control and phenobarbital (PB)-pretreated (80 mg/kg, ip daily for 3 days) adult male Wistar rats. As(III) administration to PBpretreated rats [PB + As(III)] caused hydropic degeneration, total loss of glycogen, necrosis in some centrilobular zones, and an increase in lipid vacuoles around the periportal area. Electron microscopy showed an increased number of vacuoles and autophagosomes containing organelle-like material. There was a 30% decrease in total hepatic cytochrome P-450 (CYP450). O -dealkylation of ethoxy-and pentoxyresorufin and N -demethylation of benzphetamine decreased to 42, 32, and 30% of control values, respectively. 5-Aminolevulinic acid dehydrase decreased 25% from controls, and metal chelatase activities decreased to 25% of the PB-treated group. Injection of As(III) alone resulted in a mild increase in lipid-containing vacuoles around the periportal zone, a moderate loss of glycogen in midzonal areas, and, by electron microscopy, a dilatation of the bile canaliculi and an increase of the number of myelinlike structures. CYP450 content and the O-dealkylation of ethoxy-and pentoxyresorufin and N -demethylation of benzphetamine all decreased between 30 and 50%. These results demonstrate the greater susceptibility of the liver to injury following PB with compounds not requiring metabolic activation. The metabolic basis of these changes are unclear but may result from an increased demand for metabolic energy due to PB induction and decreased adenosine triphosphate synthesis caused by arsenic.
INTRODUCTION
The toxic effects of environmental contaminants are modified by pre-or concurrent exposure to drugs or other toxicants. There are few data on how arsenic (As) toxicity can be modified by induction of the cytochrome P-450 (CYP450) system by phenobarbital (PB). Long-term exposure to As causes liver cirrhosis and cancer in humans (1, 8) and liver enlargement, cell degeneration, jaundice, and fibrosis in dogs and rats (1) . Furthermore, sodium arsenite [As(III)] alters hepatic heme metabolism and decreases microsomal CYP450 (3, 7) and mixed-function oxidase (MFO) activity (2) . It is well known that PB, a potent MFO inducer (2, 5) , increases liver size, peroxisomes, and the number (but not surface area) of mitochondria in hepatocytes (30) and induces smooth endoplasmic reticulum proliferation (28) . It is therefore likely that MFO inducers would alter the hepatotoxic effects of As(III). The aim of the present study was to monitor morphology and biochemistry changes that would characterize the hepatotoxic effects of As(III) in PB-induced livers. An understanding of these processes is required for a valid risk assessment of how As(III) toxicity may be modulated by exposure to other chemicals. We have shown that concomitant exposure to PB and then As(III) caused more marked morphological degeneration and biochemical changes than either compound on its own.
MATERIALS AND METHODS

Reagents
As(III) (Merck GmbH, Darmstadt, Germany), periodic acid, PB sodium salt, DPX mountant and fibrowax (British Drug House, Poole, Dorset, UK), glutaraldehyde, Epon-812 and other electron microscopy consumables (TAAB Laboratories Equipment Ltd., Reading, Berkshire, UK), photographic material (Eastman Kodak Co., Rochester, NY, USA), benzphetamine, NADPH, a-amylase and osmic acid (Sigma Chemical Co., Poole, Dorset, UK), resorufin and 7-ethoxyresorufin (Pierce and Warriner Ltd., Chester Cheshire, UK), 7-pentoxyresorufin (Molecular Probes, Junction City, OR, USA), and carbon monoxide (British Oxygen Co., London, UK) were all purchased from the sources indicated. All other chemicals were of the highest analytical grade available.
Animals and Treatments
Male Wistar rats of the University of Surrey strain (200-250 g) were housed in plastic cages with sawdust bedding (Lee and Co., Chertsey, Surrey, UK) and main- As(III) on the histology of control and PB-pretreated rats.a a Rats received saline (control), As(III) 75 fLmol/kg body weight in saline sc, PB 80 mg/kg body weight in saline ip, daily for 3 days (PB), or both (PB + As(Ill)) and were sacrificed 16 hr after As(III) treatment, animals were given free access to rat chow (see the Materials and Methods section). tained on a 12-hr light/dark cycle starting at 0700 hours, at a temperature of 22 ± 3°C and 50% relative humidity. Rats were given free access to feed (laud-1, K&K, Croydon, UK) and allowed tap water ad libitum. Control rats received only 1 injection of As(III) (75 j.1mol/kg, in saline, sc). PB-treated rats received 3 consecutive daily injections of PB (80 mg PB/kg in saline, ip). Rats treated with PB + As(III) received the As(III) at the same time as the last PB injection. Controls were given saline as appropriate. All rats were sacrificed by cervical dislocation, 16 hr after As(III) or its vehicle injection.
Tissue Preparation All morphological changes were assessed independently by 2 pathologists.
Light Microscopy. Samples from the left, right, median, and caudal hepatic lobes were fixed in phosphatebuffered formalin for light microscopy. Representative samples from each lobe were dehydrated in graded ethanol solutions and embedded in paraffin (10) . The paraffin-embedded tissues were sectioned and stained with hematoxylin and eosin or with periodic acid-Schiff (PAS). The latter procedure was done both before and after digestion with a-amylase (10). Formalin-fixed tissues were prepared as ,frozen sections using a freezing stage microtome and stained for lipids using Oil red &dquo;0&dquo; (10) . Electron Microscopy Preparations. Samples from only the median lobe were processed for ultrastructural studies by rapidly slicing into 0.5-1-mm cubes with a scalpel moistened in fixative (4% v/v glutaraldehyde in pH 7.4, 0.1 M cacodylate-HN03 buffer) and then counterfixed with 2% w/v osmic acid, embedded, cut, and counterstained with lead and uranyl acetate (23) . Sections were examined under a JEOL-400 (Japanese Electronic and Optical Company, Akishima, Japan) electron microscope.
Biochemical Assays
Microsome Preparation. A piece of liver (approximately 4 g) was minced and homogenized using ice-cold Tris-HCI 0.01 M, sucrose 0.25 M buffer at pH 7.4. The homogenates were centrifuged at 800 X g; then, the supernatant was centrifuged at 10,000 X g to separate mitochondria and the pellet was later resuspended in sucrose 0.25 M, whereas the supernatant was centrifuged at 105,000 X g for 1 hr. The supernatant constituted the soluble cytosolic fraction and the microsomes in the pellet were washed once more with buffer. The microsomal fraction was resuspended to reach a ratio of 20 mg of microsomal protein/ml. Microsomes were divided in 1ml aliquots and frozen immediately and kept at -70°C until used.
Microsomal and Heme Metabolism Enzymes. The 0dealkylation of 7-ethoxy-and pentoxyresorufin was assayed by monitoring resorufin fluorescence (6) , whereas the N-demethylation of benzphetamine was measured by following the oxidation of NADPH spectrophotometrically (22) . The total hepatic concentration of microsomal CYP450 was assessed by measuring its reduced-CO spectra (27) . The metal chelatase activity was measured in the mitochondrial fraction by monitoring the incorporation of Co2+ into mesoporphyrin III (12) . The 5-aminolevulinic acid dehydrase activity was assayed in the soluble cytosolic fraction by the formation of porphobilinogen, which forms a red-colored compound with p-dimethylaminobenzaldehyde (19) .
The heme oxygenase activity was assayed in the microsomal fraction by measuring the formation of bilirubin using heme as substrate and the cytosol of a control rat liver as a source of biliverdin reductase; this enzyme converts biliverdin, the heme oxygenase product, into bilirubin (32) . The NADPH-cytochrome c (P-450) reductase activity was assayed by monitoring the electron transfer from NADPH to cytochrome c using a spectrophotometer (31) .
Statistical Analysis
Statistical significance between sets of data was determined by ANOVA pairwise multiple Student-Newman-Keuls methods and the level of significance at p S 0.05.
RESULTS
Light Microscopy
A summary of the major changes is presented in Table  I , and specific aspects are shown in Figs. 1 and 2 . Control sections showed typical normal liver morphology (Fig.  la ) and the absence of lipid staining (Fig. 2a ), and content of glycogen in these sections indicated normal (Fig.   3a ), fed animals. In contrast, As(III) alone resulted in a mild vacuolation in the periportal zone, some lipid accumulation (Fig. 2b ), and glycogen depletion in the midzonal areas of the liver (Fig. 3b ). PB pretreatment resulted in a centrilobular eosinophilic region but not in lipid accumulation. However, a marked decrease in the hepatic glycogen was seen in the periportal and midzonal areas (Fig. 3c ). The liver of PB-pretreated rats injected with As(III) showed centrilobular hydropic degeneration (Fig. lb) , scattered necrosis with increased periportal lipid vacuolation (Fig. 2c) , and a total loss of glycogen (Fig.   3d ).
Electron Microscopy
A summary of the major ultrastructural changes is presented in Table II . Control sections showed a normal ultrastructural appearance with glycogen particles and wellorganized rough endoplasmic reticulum stacks; mitochondria also showed a normal morphology with welldefined matrix and cristae (Fig. 4a ). The ultrastructural features in the livers of rats treated with As(III) alone included some dilatation of the bile canaliculi (which contained myelin-like figures) and a moderate increase in vacuolation; some mitochondria appeared swollen or were undergoing degeneration, which could lead to the formation of the myelin-like figures. The rough endoplasmic reticulum appeared as short layers, and there was an increase in the number of peroxisomes (Fig. 4b ). The changes caused by PB pretreatment included the formation of myelin-like figures, degenerated mitochondria, and moderate loss of glycogen (Fig. 4c ). The administration of PB + As(III) caused ultrastructural changes resembling those caused by each chemical alone, but the severity was considerably more marked (Fig. 4d ). The liver changes included dilatation of the bile canaliculi containing myelin-like figures and swollen microvilli and an increase in lipid vacuolation. Mitochondria that were not normal were either condensed or swollen and, in some cases, were undergoing degeneration. There was a moderate increase in the number of &dquo;coreless&dquo; peroxisomes and a severe disorganization of the rough endoplasmic reticulum, where vesicles of smooth endoplasmic reticulum also appeared. The PB + As(III) treatment also caused complete depletion of glycogen and the appearance of some autophagosomes containing organelle-like material.
Biochemical Assays
As expected, PB pretreatment caused a significant increase in CYP450 content, 7-ethoxyresorufin O-deethylase and pentoxyresorufin O-dealkylase, and benzphetamine N-demethylase activities. As(III) given alone to control rats caused significant decreases in the hepatic CYP450 content and the O-dealkylation of ethoxyreso- (Table III) , whereas heme oxygenase activity increased significantly. By contrast, As(III) injection to PBpretreated rats resulted in a significant decrease of 7ethoxyresorufin O-deethylase and pentoxyresorufin O-dealkylase and benzphetamine N-demethylase activities and also significantly decreased 5-aminolevulinic acid dehydrase and metal chelatase activities (Table IV) . DISCUSSION Multiple chemical exposure represents a realistic picture of the human &dquo;chemical burden,&dquo; but there is still only a limited understanding of the process that alters the expression of toxicity and hence a limited knowledge base from which to make risk assessments. In the case of As(III), there are some data to show that other metals can alter its toxic effects. Acute exposure to both As(III) and cadmium decrease hepatic glutathione levels and increase the toxicity (15) , whereas high doses (1,000 j.1mol/ kg) of zinc protect against As(III) toxicity, probably due to metallothionein induction (21) .
There is a paucity of data on the interactions between As(III) and organic chemicals. Humans are exposed to a wide range of therapeutic agents, natural products, and environmental contaminants (35) , many of which have the potential to induce MFO systems (26) . Thus, an understanding of interaction between substances affecting the hepatic MFO system and As(III) are highly relevant to a more realistic risk assessment for As(III).
We have therefore used a model system in which the effects of As(III) were assessed in rats pretreated with PB to induce the MFO system. This study is the first to demonstrate that induction of the MFO system exacerbates the acute hepatotoxicity of As(III) in rats, as judged by more marked biochemical changes and extensive histological and ultrastructural abnormalities. For instance, light microscopy showed that As(III) injection to PB-pretreated rats caused extensive loss of glycogen, increased lipid vacuolation, and hydropic degeneration with scattered necrotic cells. Ultrastructural changes were especially marked by mitochondrial changes (some degenerative), a moderate increase in the number of &dquo;coreless&dquo; peroxisomes, a severe disorganization of both the rough and the smooth endoplasmic reticula, and the appearance of some autophagosomes containing organelle-like material. In addition, there was a significant decrease in the activity of 5-aminolevulinic acid dehydrase and ferrochelatase activities. Taken together, these changes indicate that As(III) has a greater toxic effect in PB-pretreated animals than is caused by either As(III) or PB alone.
Although enhanced hepatotoxicity of organic chemicals, such as carbon disulfide, following MFO induction are easily explained (4, 11) , exacerbation of As(III) toxicity is more difficult to understand. The mechanism of As(III) hepatotoxicity appears to be multifaceted, as lipid peroxidation (15) , complexing with reduced glutathione (14, 25, 29) , and decreased adenosine triphosphate (ATP) synthesis (9, 17) have all been implicated in the molecular mechanism. PB pretreatment has no effects on hepatic glutathione (25) ; thus, the important relationship between changes in this antioxidant (14, 15, 18, 29) and As(III) toxicity cannot be implicated in the exacerbated toxicity seen in this investigation. The role of CYP450 appears to be more strongly implied in the enhanced toxicity we have described, based on the more marked cen- trilobular liver necrosis, probably due to the differential distribution of MFO enzymes across the zones of the hepatic acini and poor oxygenation of this zone (16, 34) .
The administration of As(III) to PB-pretreated rats caused a total depletion of hepatic glycogen, a change considered to be an early indicator of toxicity (24) . The underlying mechanism is not clear but could be explained by a greater demand for energy caused by the combined treatment, because As inhibits ATP synthesis (9, 17) and PB leads to a requirement for more ATP for both increased CYP450 apoprotein (13) and heme synthesis (33) . In addition, the heme would be more readily degraded as As(III) increases heme oxygenase activities and promotes its biliary excretion (3) . Thus, the futile synthesis of the apoprotein and heme would make demands for ATP extensive. The resulting energy deficiency would markedly alter cellular physiology in several ways. Hydropic degeneration could result from As(III) inhibition of the ATP-dependent ion pumps, and lipid accumulation would represent mobilization from adipose tissues. The ultrastructural changes (dilatation of the Golgi complex and degranulation and disorganization of rough endoplasmic reticulum) in animals treated with PB and As(III) are consistent with ATP depletion. The vesiculation and disorganization of smooth endoplasmic reticulum and formation of myelin-like figures may be attributed to alterations of the membrane lipophilic environment (36) . The increase in heme oxygenase, a stress protein (20) , correlates with a depletion of CYP450 content and MFO activities.
In summary, the administration of As(III) to PB-pretreated rats caused greater hepatic injury as assessed by light and ultrastructural morphology than those resulting from As(III) injection or PB pretreatment alone. In addition, 5-aminolevulinic acid dehydrase activity was significantly decreased in the liver of the animals treated with both compounds compared to animals receiving only As(III) or PB, whereas metal chelatase activity was significantly different from the PB-pretreated rats. These data provide evidence for an additive hepatotoxic interaction between PB-induced livers and As(III) treatment. This can constitute a higher risk for humans exposed to As if they also have an enhancement of MFO activity due to alcohol, drugs, or other organic inducers.
